As of today (2024-06-05), Mega Genomics's share price is HK$9.98.
Mega Genomics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.66. Hence, Mega Genomics's Price-to-Free-Cash-Flow Ratio for today is 15.05.
The historical rank and industry rank for Mega Genomics's Price-to-Free-Cash-Flow or its related term are showing as below:
HKSE:06667'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 12.44 Med: 45.04 Max: 71.59
Current: 15.05
During the past 5 years, Mega Genomics's highest Price-to-Free-Cash-Flow Ratio was 71.59. The lowest was 12.44. And the median was 45.04.
HKSE:06667's Price-to-Free-Cash-Flow is ranked better than 72.29% of 83
companies
in the Medical Diagnostics & Research industry
Industry Median: 26.17
vs HKSE:06667: 15.05
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 9.30% per year.
During the past 5 years, Mega Genomics's highest 3-Year average Free Cash Flow per Share Growth Rate was 9.30% per year. The lowest was 9.30% per year. And the median was 9.30% per year.
Mega Genomics Price-to-Free-Cash-Flow Historical Data
The historical data trend for Mega Genomics's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mega Genomics's Price-to-Free-Cash-Flow
For the Diagnostics & Research subindustry, Mega Genomics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mega Genomics's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mega Genomics's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Mega Genomics's Price-to-Free-Cash-Flow falls into.
Mega Genomics Price-to-Free-Cash-Flow Calculation
Mega Genomics's Price-to-Free-Cash-Flow ratio for today is calculated as
Mega Genomics's Share Price of today is HK$9.98.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mega Genomics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.66.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Mega Genomics (HKSE:06667) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Mega Genomics Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Mega Genomics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening and infectious disease diagnosis, to meet consumers' growing preventive medical needs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06667 has been successfully added to your